GlassScriptPhysician profile
Brian Paul Rubin
NPI 1255498333
$21,807.58
in general payments reported to CMS, 2019-2025
10 companies · $7,532 in 2025
The $7,532 reported for 2025 was more than what 88% of Anatomic Pathology providers received nationally (typical 2025 total: $110).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $9,000 · 2021: $3,523 · 2022: $68.72 · 2023: $1,683 · 2025: $7,532.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,600 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,605 · Travel and Lodging: $1,302 · Food and Beverage: $709.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,600.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,605.00 |
| Travel and Lodging | $1,301.90 |
| Food and Beverage | $708.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Deciphera Pharmaceuticals INC. | $12,200.00 | 2020-2025 | Romvimza |
| Bayer Healthcare Pharmaceuticals INC. | $3,375.00 | 2021 | |
| Eli Lilly and Company | $2,400.00 | 2020 | |
| Siemens Medical Solutions USA, INC. | $1,883.23 | 2023-2025 | Atellica Ch 930 Analyzer, Magnetom Vida, Biograph Trinion Ep Ct64 |
| Ipsen Biopharmaceuticals, INC | $1,605.00 | 2025 | Tazverik |
| Ge Healthcare | $127.37 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $110.83 | 2021 | |
| W. L. Gore & Associates, INC. | $106.15 | 2021-2022 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Rubin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.